IL238036B - A solid oral pharmaceutical formulation containing ticagrelor - Google Patents
A solid oral pharmaceutical formulation containing ticagrelorInfo
- Publication number
- IL238036B IL238036B IL238036A IL23803615A IL238036B IL 238036 B IL238036 B IL 238036B IL 238036 A IL238036 A IL 238036A IL 23803615 A IL23803615 A IL 23803615A IL 238036 B IL238036 B IL 238036B
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical formulation
- formulation containing
- solid oral
- oral pharmaceutical
- containing ticagrelor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZ2012-705A CZ2012705A3 (en) | 2012-10-16 | 2012-10-16 | Solid oral pharmaceutical formulation containing ticagrelor |
| PCT/CZ2013/000130 WO2014059955A1 (en) | 2012-10-16 | 2013-10-15 | A solid oral pharmaceutical formulation containing ticagrelor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL238036A0 IL238036A0 (en) | 2015-05-31 |
| IL238036B true IL238036B (en) | 2019-05-30 |
Family
ID=49619770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL238036A IL238036B (en) | 2012-10-16 | 2015-03-30 | A solid oral pharmaceutical formulation containing ticagrelor |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP2908802A1 (en) |
| JP (1) | JP6301934B2 (en) |
| KR (1) | KR20150067153A (en) |
| CN (1) | CN104661649A (en) |
| BR (1) | BR112015008076A2 (en) |
| CZ (1) | CZ2012705A3 (en) |
| EA (1) | EA201590745A1 (en) |
| HK (1) | HK1205456A1 (en) |
| IL (1) | IL238036B (en) |
| MX (1) | MX2015003866A (en) |
| UA (1) | UA116784C2 (en) |
| WO (1) | WO2014059955A1 (en) |
| ZA (1) | ZA201501954B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20160012706A (en) * | 2014-07-25 | 2016-02-03 | 동아에스티 주식회사 | Sustained release formulations |
| CN106074357B (en) * | 2015-04-29 | 2021-07-02 | 江苏恒瑞医药股份有限公司 | Ticagrelor preparation of pharmaceutically acceptable salt thereof |
| CN105193759B (en) * | 2015-09-18 | 2018-07-03 | 乐普药业股份有限公司 | A kind of ticagrelor piece and preparation method thereof |
| CN106667926B (en) * | 2015-11-09 | 2020-01-17 | 石药集团中奇制药技术（石家庄）有限公司 | Favipiravir tablet and preparation method thereof |
| TR201601835A2 (en) * | 2016-02-12 | 2017-08-21 | Ali Raif Ilac Sanayi Ve Ticaret Anonim Sirketi | PRODUCTION METHOD FOR FORMULATIONS CONTAINING TIKAGRELOR |
| EA201892150A1 (en) * | 2016-04-21 | 2019-05-31 | Астразенека Аб | DECOMING IN THE ORAL CAVITY TABLETS |
| TR201617983A2 (en) * | 2016-12-07 | 2018-06-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF TICAGRELOR |
| KR102610876B1 (en) * | 2018-03-05 | 2023-12-06 | 주식회사 파마코스텍 | Crystal form I of Ticagrelor Fumarateand its preparing method |
| EP3761965A1 (en) | 2018-03-08 | 2021-01-13 | Pharmaceutical Oriented Services Ltd | Ticagrelor-containing tablet formulation |
| EA202190328A1 (en) | 2018-07-27 | 2021-07-01 | КРКА, д.д., НОВО МЕСТО | PHARMACEUTICAL COMPOSITION CONTAINING TICAGRELOR |
| CN111450067A (en) * | 2019-01-18 | 2020-07-28 | 北京万全德众医药生物技术有限公司 | Ticagrelor dispersible tablet and preparation method thereof |
| CN116370423A (en) * | 2023-02-28 | 2023-07-04 | 天津力生制药股份有限公司 | Ticagrelor orally disintegrating tablet and preparation method thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR017014A1 (en) | 1997-07-22 | 2001-08-22 | Astrazeneca Ab | TRIAZOL COMPOUNDS [4,5-D] PYRIMIDINE, PHARMACEUTICAL COMPOSITIONS, USE OF THE SAME TO PREPARE MEDICATIONS AND PROCESSES FOR THE PREPARATION OF SUCH COMPOUNDS |
| JPH11199517A (en) * | 1997-10-31 | 1999-07-27 | Meiji Seika Kaisha Ltd | Intraoral fast disintegrable tablet |
| TWI229674B (en) | 1998-12-04 | 2005-03-21 | Astra Pharma Prod | Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses |
| GB0013407D0 (en) * | 2000-06-02 | 2000-07-26 | Astrazeneca Ab | Forms of a chemical compound |
| WO2007018057A1 (en) * | 2005-08-05 | 2007-02-15 | Freund Corporation | Tablet rapidly disintegrating in the oral cavity and method of producing the same |
| TWI482772B (en) | 2006-08-21 | 2015-05-01 | Astrazeneca Ab | Compositions, suitable for oral administration, comprising a triazolo(4,5-d)pyrimidin derivate |
| US20080045548A1 (en) | 2006-08-21 | 2008-02-21 | Astrazeneca Ab | Pharmaceutical Compositions |
| MX2012006375A (en) | 2009-12-03 | 2013-03-21 | Astrazeneca Ab | Co - crystals of a triazolo [4,5 - d] pyrimidine platelet aggregation inhibitor. |
| EA026094B1 (en) | 2009-12-23 | 2017-03-31 | Рациофарм Гмбх | Solid dosage form of ticagrelor |
-
2012
- 2012-10-16 CZ CZ2012-705A patent/CZ2012705A3/en unknown
-
2013
- 2013-10-15 WO PCT/CZ2013/000130 patent/WO2014059955A1/en active Application Filing
- 2013-10-15 MX MX2015003866A patent/MX2015003866A/en unknown
- 2013-10-15 CN CN201380050404.5A patent/CN104661649A/en active Pending
- 2013-10-15 EP EP13792574.9A patent/EP2908802A1/en not_active Withdrawn
- 2013-10-15 BR BR112015008076A patent/BR112015008076A2/en not_active IP Right Cessation
- 2013-10-15 UA UAA201504754A patent/UA116784C2/en unknown
- 2013-10-15 KR KR1020157007818A patent/KR20150067153A/en not_active Application Discontinuation
- 2013-10-15 JP JP2015535983A patent/JP6301934B2/en not_active Expired - Fee Related
- 2013-10-15 EA EA201590745A patent/EA201590745A1/en unknown
-
2015
- 2015-03-20 ZA ZA2015/01954A patent/ZA201501954B/en unknown
- 2015-03-30 IL IL238036A patent/IL238036B/en not_active IP Right Cessation
- 2015-06-24 HK HK15106027.7A patent/HK1205456A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2015003866A (en) | 2015-07-17 |
| BR112015008076A2 (en) | 2017-07-04 |
| HK1205456A1 (en) | 2015-12-18 |
| CZ2012705A3 (en) | 2014-04-23 |
| IL238036A0 (en) | 2015-05-31 |
| CN104661649A (en) | 2015-05-27 |
| JP6301934B2 (en) | 2018-03-28 |
| EP2908802A1 (en) | 2015-08-26 |
| ZA201501954B (en) | 2017-04-26 |
| EA201590745A1 (en) | 2015-08-31 |
| KR20150067153A (en) | 2015-06-17 |
| WO2014059955A1 (en) | 2014-04-24 |
| JP2015533129A (en) | 2015-11-19 |
| UA116784C2 (en) | 2018-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1211209A1 (en) | Pharmaceutical formulation containing thienotriazolodiazepine compounds | |
| HK1205456A1 (en) | A solid oral pharmaceutical formulation containing ticagrelor | |
| EP2906202A4 (en) | Oral drug delivery formulations | |
| HRP20181193T1 (en) | Oral administrable pharmaceutical composition | |
| HK1199821A1 (en) | Oral pharmaceutical composition | |
| GB2486567B (en) | Pharmaceutical formulation | |
| HK1205146A1 (en) | Pharmaceutical formulation | |
| ZA201501897B (en) | A pharmaceutical composition | |
| LT2934544T (en) | Pharmaceutical formulation comprising ciclesonide | |
| HK1207290A1 (en) | Oral formulation | |
| LT2895171T (en) | A stable pharmaceutical formulation containing vardenafil hydrochloride | |
| PL2908836T3 (en) | Pharmaceutical formulation containing curcuma | |
| HK1204945A1 (en) | Pharmaceutical formulation containing flupirtin | |
| HK1209339A1 (en) | Pharmaceutical formulations | |
| GB201211406D0 (en) | Pharmaceutical formulations | |
| GB201211403D0 (en) | Pharmaceutical formulations | |
| GB201221367D0 (en) | A pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| MM9K | Patent not in force due to non-payment of renewal fees |